Accordingly, in the present study, in particular, there were significant changes in the VEGF antibody levels between the control group and treated patients as well as between untreated and treated patients (AMD 1 and 7), highlighting a possible treatment-induced effect. Here, VEGFA is linked to age-related macular degeneration.